373 related articles for article (PubMed ID: 8104889)
1. Endotoxin activation of endothelium for polymorphonuclear leucocyte transendothelial migration and modulation by interferon-gamma.
Issekutz AC; Lopes N
Immunology; 1993 Aug; 79(4):600-7. PubMed ID: 8104889
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration.
Ebisawa M; Bochner BS; Georas SN; Schleimer RP
J Immunol; 1992 Dec; 149(12):4021-8. PubMed ID: 1460288
[TBL] [Abstract][Full Text] [Related]
3. The contribution of LFA-1 (CD11a/CD18) and MAC-1 (CD11b/CD18) to the in vivo migration of polymorphonuclear leucocytes to inflammatory reactions in the rat.
Issekutz AC; Issekutz TB
Immunology; 1992 Aug; 76(4):655-61. PubMed ID: 1398754
[TBL] [Abstract][Full Text] [Related]
4. Polymorphonuclear leucocyte migration through human dermal fibroblast monolayers is dependent on both beta 2-integrin (CD11/CD18) and beta 1-integrin (CD29) mechanisms.
Gao JX; Issekutz AC
Immunology; 1995 Jul; 85(3):485-94. PubMed ID: 7558139
[TBL] [Abstract][Full Text] [Related]
5. VLA-4 integrin can mediate CD11/CD18-independent transendothelial migration of human monocytes.
Chuluyan HE; Issekutz AC
J Clin Invest; 1993 Dec; 92(6):2768-77. PubMed ID: 7902847
[TBL] [Abstract][Full Text] [Related]
6. Migration of human polymorphonuclear leukocytes through a synovial fibroblast barrier is mediated by both beta 2 (CD11/CD18) integrins and the beta 1 (CD29) integrins VLA-5 and VLA-6.
Gao JX; Wilkins J; Issekutz AC
Cell Immunol; 1995 Jul; 163(2):178-86. PubMed ID: 7541723
[TBL] [Abstract][Full Text] [Related]
7. Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration.
Drake WT; Lopes NN; Fenton JW; Issekutz AC
Lab Invest; 1992 Nov; 67(5):617-27. PubMed ID: 1434539
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 enhances polymorphonuclear leucocyte accumulation in dermal inflammation and transendothelial migration by a priming action.
Drake WT; Issekutz AC
Immunology; 1993 Feb; 78(2):197-204. PubMed ID: 8473013
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor-alpha but not interleukin-1 induces polymorphonuclear leucocyte migration through fibroblast layers by a fibroblast-dependent mechanism.
Morzycki W; Issekutz AC
Immunology; 1991 Sep; 74(1):107-13. PubMed ID: 1937564
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 and tumour necrosis factor alpha induced polymorphonuclear leukocyte-endothelial cell adhesion and transendothelial migration in vitro: the effect of apical versus basal monolayer stimulation.
Morzycki W; Sadowska J; Issekutz AC
Immunol Lett; 1990 Sep; 25(4):331-40. PubMed ID: 2249877
[TBL] [Abstract][Full Text] [Related]
11. Cytokine activation of human macro- and microvessel-derived endothelial cells.
Gerritsen ME; Niedbala MJ; Szczepanski A; Carley WW
Blood Cells; 1993; 19(2):325-39; discussion 340-2. PubMed ID: 7906155
[TBL] [Abstract][Full Text] [Related]
12. Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer.
Lou J; Gasche Y; Zheng L; Giroud C; Morel P; Clements J; Ythier A; Grau GE
Lab Invest; 1999 Aug; 79(8):1015-25. PubMed ID: 10462039
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion.
Spertini O; Luscinskas FW; Kansas GS; Munro JM; Griffin JD; Gimbrone MA; Tedder TF
J Immunol; 1991 Oct; 147(8):2565-73. PubMed ID: 1717567
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells in vitro.
Leeuwenberg JF; von Asmuth EJ; Jeunhomme TM; Buurman WA
J Immunol; 1990 Oct; 145(7):2110-4. PubMed ID: 1697876
[TBL] [Abstract][Full Text] [Related]
15. E-selectin (endothelial-leukocyte adhesion molecule-1) is not required for the migration of neutrophils across IL-1-stimulated endothelium in vitro.
Furie MB; Burns MJ; Tancinco MC; Benjamin CD; Lobb RR
J Immunol; 1992 Apr; 148(8):2395-404. PubMed ID: 1373167
[TBL] [Abstract][Full Text] [Related]
16. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.
Pober JS; Gimbrone MA; Lapierre LA; Mendrick DL; Fiers W; Rothlein R; Springer TA
J Immunol; 1986 Sep; 137(6):1893-6. PubMed ID: 3091693
[TBL] [Abstract][Full Text] [Related]
17. Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration.
Chuluyan HE; Osborn L; Lobb R; Issekutz AC
J Immunol; 1995 Sep; 155(6):3135-4. PubMed ID: 7545712
[TBL] [Abstract][Full Text] [Related]
18. Mac-1 (CD11b/CD18) is the predominant beta 2 (CD18) integrin mediating human neutrophil migration through synovial and dermal fibroblast barriers.
Gao JX; Issekutz AC
Immunology; 1996 Jul; 88(3):463-70. PubMed ID: 8774366
[TBL] [Abstract][Full Text] [Related]
19. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms.
Issekutz AC; Chuluyan HE; Lopes N
J Leukoc Biol; 1995 Apr; 57(4):553-61. PubMed ID: 7722414
[TBL] [Abstract][Full Text] [Related]
20. Effect of a new monoclonal antibody, TA-2, that inhibits lymphocyte adherence to cytokine stimulated endothelium in the rat.
Issekutz TB; Wykretowicz A
J Immunol; 1991 Jul; 147(1):109-16. PubMed ID: 1711066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
